GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com


Jump to: navigation, search

Rasmussen, BA, Kim, E, Unterwald, EM and Rawls, SM (2009) Methanandamide attenuates cocaine-induced hyperthermia in rats by a cannabinoid CB1-dopamine D2 receptor mechanism. Brain Res. 1260:7-14


Evidence implicates anandamide in dopamine-related cocaine function. In the present study, we investigated the effect of methanandamide (5 mg/kg, i.p.), a stable anandamide analog, on the hyperthermia and hyperactivity induced by a fixed dose of cocaine (15 mg/kg,i.p.). Cocaine administered to rats produced hyperthermia and hyperactivity whereas methanandamide was ineffective. For combined administration, methanandamide attenuated the hyperthermia, but not hyperactivity, induced by cocaine. The effect of methanandamide was abolished by pretreatment with a cannabinoid CB1 receptor antagonist, SR141716A (5 mg/kg, i.p.), or dopamine D2 receptor antagonist, S(−)-raclopride(5 mg/kg, i.p.) but not by capsazepine (40 mg/kg, i.p.), a transient receptor potential vanilloid 1 cation channel antagonist. Methanandamide also attenuated the hyperthermia caused by a dopamine D1 receptor agonist, SKF 38393 (10 mg/kg, s.c.), indicating that it reduces hyperthermia produced by dopamine D1 receptor activation. URB597 (0.25 mg/kg, i.p.), an inhibitor of anandamide metabolism, did not alter cocaine-induced hyperthermia. Our results demonstrate that methanandamide activates cannabinoid CB1 receptors to attenuate cocaine-induced hyperthermia, and that dopamine D2 receptor activation plays a permissive role in the thermoregulatory effects of methanandamide.


PubMed PMC4081499 Online version:10.1016/j.brainres.2008.12.078


Animals; Arachidonic Acids/pharmacology; Cannabinoid Receptor Modulators/pharmacology; Cocaine/pharmacology; Dopamine Uptake Inhibitors/pharmacology; Fever/chemically induced; Fever/drug therapy; Fever/physiopathology; Male; Motor Activity/drug effects; Motor Activity/physiology; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1/metabolism; Receptors, Dopamine D1/agonists; Receptors, Dopamine D1/metabolism; Receptors, Dopamine D2/metabolism; TRPV Cation Channels/antagonists & inhibitors; TRPV Cation Channels/metabolism



Gene product Qualifier GO Term Evidence Code with/from Aspect Extension Notes Status



GO:0042220: response to cocaine

ECO:0000315: mutant phenotype evidence used in manual assertion


Seeded From UniProt



See also


See Help:References for how to manage references in GONUTS.